The Europe Transfer Membrane Market should witness market growth of 4.0% CAGR during the forecast period (2022-2028).
Dry electroblotting techniques use a unique transfer sandwich with cutting-edge components that do not need conventional transfer buffers. Instead of buffer tanks or soaked filter papers, a unique gel matrix (transfer stack) with buffer is used. Rapid protein transfer is made possible by the gel matrix's high ionic density. Blot distortion is decreased because water electrolysis at the copper anode does not produce oxygen gas during blotting. Wet and semi-dry protein transfer methods use inert electrodes with oxygen.
Often, closer spacing between electrodes, a strong field, and a high current help speed up the transmission. Setup and cleaning times are considerably reduced compared to other transfer techniques since buffers don't need to be created. The thermal motion of molecules, which causes them to flow from a region of high concentration to an area of low concentration, is the basis for diffusion blotting.
The French government and pharmaceutical sector have committed to taking all necessary steps to raise medical R&D investment by 10% over the next three years. According to the French government, the new goal is to make France's pharmaceutical sector competitive in terms of R&D spending. Furthermore, various measures are already in place to encourage businesses to boost investment. Included are newly increased tax benefits for companies making R&D investments and separate tax relief for the pharmaceutical sector. The government's involvement in surging R&D in the pharmaceutical sector is expected to propel the transfer membrane market growth in the region.
The Germany market dominated the Europe Transfer Membrane Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $28,375.4 Thousands by 2028. The UK market is anticipated to grow at a CAGR of 3.2% during (2022-2028). Additionally, The France market would exhibit a CAGR of 4.8% during (2022-2028).
Based on Product, the market is segmented into PVDF, Nitrocellulose and Nylon. Based on Transfer Method, the market is segmented into Dry Electro Blotting (Dry Transfer), Semi-dry Electro Blotting (Semi-dry Transfer), Wet or Tank Transfer and Others. Based on Application, the market is segmented into Western Blotting, Southern Blotting, Northern Blotting and Others. Based on End-User, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, Academic & Research Institutes and Diagnostic Labs. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, PerkinElmer, Inc., Abcam Plc, Santa Cruz Biotechnology, Inc., ATTO Corporation, Azure Biosystems, Inc., and GVS S.p. A.
Dry electroblotting techniques use a unique transfer sandwich with cutting-edge components that do not need conventional transfer buffers. Instead of buffer tanks or soaked filter papers, a unique gel matrix (transfer stack) with buffer is used. Rapid protein transfer is made possible by the gel matrix's high ionic density. Blot distortion is decreased because water electrolysis at the copper anode does not produce oxygen gas during blotting. Wet and semi-dry protein transfer methods use inert electrodes with oxygen.
Often, closer spacing between electrodes, a strong field, and a high current help speed up the transmission. Setup and cleaning times are considerably reduced compared to other transfer techniques since buffers don't need to be created. The thermal motion of molecules, which causes them to flow from a region of high concentration to an area of low concentration, is the basis for diffusion blotting.
The French government and pharmaceutical sector have committed to taking all necessary steps to raise medical R&D investment by 10% over the next three years. According to the French government, the new goal is to make France's pharmaceutical sector competitive in terms of R&D spending. Furthermore, various measures are already in place to encourage businesses to boost investment. Included are newly increased tax benefits for companies making R&D investments and separate tax relief for the pharmaceutical sector. The government's involvement in surging R&D in the pharmaceutical sector is expected to propel the transfer membrane market growth in the region.
The Germany market dominated the Europe Transfer Membrane Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $28,375.4 Thousands by 2028. The UK market is anticipated to grow at a CAGR of 3.2% during (2022-2028). Additionally, The France market would exhibit a CAGR of 4.8% during (2022-2028).
Based on Product, the market is segmented into PVDF, Nitrocellulose and Nylon. Based on Transfer Method, the market is segmented into Dry Electro Blotting (Dry Transfer), Semi-dry Electro Blotting (Semi-dry Transfer), Wet or Tank Transfer and Others. Based on Application, the market is segmented into Western Blotting, Southern Blotting, Northern Blotting and Others. Based on End-User, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, Academic & Research Institutes and Diagnostic Labs. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, PerkinElmer, Inc., Abcam Plc, Santa Cruz Biotechnology, Inc., ATTO Corporation, Azure Biosystems, Inc., and GVS S.p. A.
Scope of the Study
By Product
- PVDF
- Nitrocellulose
- Nylon
By Transfer Method
- Dry Electro Blotting (Dry Transfer)
- Semi-dry Electro Blotting (Semi-dry Transfer)
- Wet or Tank Transfer
- Others
By Application
- Western Blotting
- Southern Blotting
- Northern Blotting
- Others
By End-User
- Biopharmaceutical & Pharmaceutical Companies
- Academic & Research Institutes
- Diagnostic Labs
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- PerkinElmer, Inc.
- Abcam Plc
- Santa Cruz Biotechnology, Inc.
- ATTO Corporation
- Azure Biosystems, Inc.
- GVS S.p. A
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Europe Transfer Membrane Market by Product
Chapter 5. Europe Transfer Membrane Market by Transfer Method
Chapter 6. Europe Transfer Membrane Market by Application
Chapter 7. Europe Transfer Membrane Market by End-User
Chapter 8. Europe Transfer Membrane Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- PerkinElmer, Inc.
- Abcam Plc
- Santa Cruz Biotechnology, Inc.
- ATTO Corporation
- Azure Biosystems, Inc.
- GVS S.p.A
Methodology
LOADING...